Kangdelai: Controlling shareholder intends to transfer 5% of the company's shares to introduce strategic investors.

On the evening of September 2nd, Kangdelai announced that its controlling shareholder, Shanghai Kangdelai Holdings Group Co., Ltd., signed a "Stock Transfer Agreement" with Changsha Xiezihao Medical Investment Co., Ltd. on September 1st. It plans to transfer 21.8395 million shares of the company's unlimited circulating shares to Changsha Xiezihao at a price of 10.81 yuan per share, with a total transfer price of 236 million yuan. This agreement transfer is to further deepen Kangdelai Group's strategic layout. The implementation of this strategy will allow the company to achieve synergies in industry and resources with strategic partners, expand development space in the consumer medical field, optimize equity structure, and enhance corporate governance.